Literature DB >> 9661947

A case of Guillain-Barré syndrome associated with human parvovirus B19 infection.

Y Minohara1, Y Koitabashi, T Kato, N Nakajima, H Murakami, H Masaki, H Ishiko.   

Abstract

We report a 4-year-old boy who presented with Guillain-Barré Syndrome 11 days after the onset of erythema infectiosum. The illness resolved without gamma globulin therapy.

Entities:  

Mesh：

Year:  1998        PMID： 9661947     DOI： 10.1016/s0163-4453(98)94531-5

Source DB:  PubMed          Journal:  J Infect        ISSN： 0163-4453            Impact factor:   6.072


  6 in total

Review 1.  Pathogenesis of human parvovirus B19 in rheumatic disease.

Authors:  J R Kerr
Journal:  Ann Rheum Dis       Date:  2000-09       Impact factor: 19.103

2.  Parvovirus B19 infection antedating Guillain-Barre' syndrome variant with prominent facial diplegia.

Authors:  Filippo Barbi; Alessandra Ariatti; Kei Funakoshi; Marisa Meacci; Masaaki Odaka; Giuliana Galassi
Journal:  J Neurol       Date:  2011-02-15       Impact factor: 4.849

Review 3.  Human Parvoviruses.

Authors:  Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

4.  Mononeuropathy multiplex associated with acute parvovirus B19 infection: characteristics, treatment and outcome.

Authors:  Timothée Lenglet; Julien Haroche; Aurélie Schnuriger; Thierry Maisonobe; Karine Viala; Yanne Michel; Farhat Chelbi; David Grabli; Paul Seror; Antoine Garbarg-Chenon; Zahir Amoura; Pierre Bouche
Journal:  J Neurol       Date:  2011-02-02       Impact factor: 6.682

Review 5.  Neurological aspects of human parvovirus B19 infection: a systematic review.

Authors:  Faraj Barah; Sigrid Whiteside; Sonia Batista; Julie Morris
Journal:  Rev Med Virol       Date:  2014-01-24       Impact factor: 6.989

6.  Guillain-Barré Syndrome Associated with Primary Parvovirus B19 Infection in an HIV-1-Infected Patient.

Authors:  Caroline Bucher Praz; Cédric Dessimoz; Frank Bally; Sitthided Reymond; Nicolas Troillet
Journal:  Case Rep Med       Date:  2012-11-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.